BRO logo

Brown & Brown

BRO · What the business does, what can go wrong, and how options sellers approach it

What it does

Brown & Brown is an insurance intermediary. It does not take on insurance risk the way a traditional insurer does. Instead, it helps businesses, public entities and individuals find and buy coverage from insurance companies.

The company operates in two main areas. Its Retail business sells insurance and related services directly to customers, including commercial, public sector, professional and individual clients. Its Specialty Distribution business includes wholesale brokerage and programs businesses that work with other agents on harder-to-place risks.

How it makes money

Most revenue comes from commissions paid by insurers when a policy is placed or renewed. The company also earns fees for advisory, claims and other services. Because commissions usually track the price of the coverage, revenue tends to rise when insurance prices rise and when the company wins new clients.

Why investors own it

Many investors like the steady, recurring nature of renewals, since clients often keep their coverage year after year. The business needs relatively little capital compared with an insurer, which can support cash generation. Acquisitions of smaller agencies have long been part of the growth strategy. Some investors also view insurance brokerage as a defensive area, because businesses generally need coverage in any economy.

What can go wrong

  • Insurance prices can flatten or fall, which pressures commissions.
  • A weak economy can shrink the amount of coverage clients buy.
  • Acquisitions carry integration risk and can add debt.
  • Competition for talent and clients is intense, and producers who leave can take clients with them.
  • Regulation, or changes in how brokers are paid, could affect the model.

What to watch

  • Organic revenue growth
  • Pricing trends in commercial insurance
  • Client retention
  • Acquisition pace and integration results
  • Profit margins
  • Debt levels after deals
  • Performance of the Retail and Specialty Distribution segments

Options income angle

Options on BRO are generally available across multiple expirations, but liquidity is usually thinner than for the largest mega-cap stocks. Bid-ask spreads can be wider, especially on strikes far from the current price.

Implied volatility tends to rise around quarterly earnings and during broad market stress. It can also move on shifts in insurance pricing trends or news about acquisitions.

One caution for premium sellers: a stock like this can gap on an earnings report, so a short call or put can move sharply against you. Covered calls may also cap gains if the shares rally strongly.

What the latest 10-K says

A plain-English read of the Risk Factors and Management's Discussion in the 10-K for the year ended December 31, 2025, filed February 12, 2026. Figures are as the filing reports them. Read the filing on SEC.gov

The filing in brief

Brown & Brown completed its purchase of Accession in 2025. That lifted total revenues to $5,902 million and total debt to $7,613 million. Most of the growth came from acquisitions, while Organic Revenue growth (growth excluding acquisitions, sales of businesses and currency effects) slowed to 2.8% from 10.4%. The filing's main themes are integrating Accession, higher debt and interest costs, and litigation tied to Accession's captive insurance programs.

How the business did

  • Total revenues rose 22.8% from $4,805 million. Core commissions and fees increased $969 million, of which $836 million came from acquisitions with no comparable revenue in 2024 and about $126 million from net new and renewal business.
  • Income before income taxes rose 5.2% to $1,371 million, and net income attributable to the company was $1,054 million, up 6.1%. Costs grew faster in places: interest expense was $297 million (up 53.9%), amortization was $312 million (up 75.3%), and Acquisition/Integration Costs were $113 million. Income Before Income Taxes Margin fell to 23.2% from 27.1%.
  • Retail revenues were $3,406 million, up 24.8%. Specialty Distribution revenues were $2,409 million, up 19.5%. Each segment's Organic Revenue growth was 2.8%. Management pointed to slowing rate increases, rate decreases in some lines and a UK regulatory change in Retail, and to declining catastrophe property rates in Specialty Distribution. Profit-sharing contingent commissions rose to $255 million from $166 million.
  • Operating cash flow was $1,450 million versus $1,174 million. The company paid $7,854 million for acquisitions, including $7,463 million for Accession. It paid $193 million in dividends and repurchased $100 million of stock.

Risks specific to this company

  • Accession integration: The filing warns that expected benefits and synergies may arrive late or not at all. It also says use of Accession's deferred tax assets may be limited.
  • Debt and near-term maturities: Total debt was $7,613 million, and interest costs will materially increase. The Revolving Credit Facility and its associated term loan, $269 million in total, mature within twelve months and no refinancing agreements were in place at year end. The $400 million 4.600% Senior Notes due 2026 are also classified as current.
  • Accession litigation and captives: Oxford Risk Management Group, an Accession subsidiary, faces litigation over the 2024 restructuring of certain financial guarantee policies. Costs above the cash in the captives and the indemnity escrow would hurt results. The IRS has also investigated peers that set up Section 831(b) captives for customers.
  • Geographic concentration: Florida produced approximately 16% of annual revenue and the United Kingdom approximately 10%. Hurricanes are a named risk, and the company's natural disaster insurance coverage is limited.
  • Soft insurance markets: Commissions are a percentage of premiums the company does not set. Falling premium rates or reduced carrier commission rates could weaken revenue and margins.
  • Goodwill: The company carries $15 billion of goodwill. No impairments were recorded for 2025, 2024 or 2023, but a sustained decline in expected cash flows could trigger a write-down.

What management is watching

  • Core performance measures: Management focuses on Organic Revenue growth and EBITDAC Margin - Adjusted (earnings before interest, taxes, depreciation, amortization and earn-out changes, excluding certain acquisition items), which was 35.9% versus 35.2%. Both measures drive executive incentive pay.
  • Accession integration costs: These costs, such as systems migration, severance and retention pay, are excluded from the adjusted measure as not part of ongoing operations.
  • Refinancing and liquidity: Management intends to refinance or extend the facilities maturing within twelve months. It drew $225 million on the Revolving Credit Facility on February 10, 2026, and says that facility provided capacity for up to $700 million in additional cash.
  • Acquisition earn-outs: Estimated earn-out payables (extra payments owed to sellers if acquired businesses hit targets) were $541 million, within maximum future acquisition contingency payments of $842 million.
  • Capital return: The board raised the share repurchase authorization, leaving approximately $1,500 million of capacity at that time.

What the latest 10-Q says

A plain-English read of Management's Discussion (and any new or changed risk factors) in the 10-Q for the quarter ended September 30, 2026, filed October 26, 2026. Figures are as the filing reports them. Read the filing on SEC.gov

The quarter in brief

Brown & Brown's total commissions and fees grew 9.7% in the third quarter of 2026, but nearly all of that came from acquisitions, mainly Accession. Organic Revenue, which strips out acquisitions, sales of businesses, currency effects and the Litigation-Related Impact, grew only 1.2%, against 3.5% a year earlier. Income before income taxes rose $9 million, or 2.9%, and EBITDAC Margin - Adjusted (a measure of operating profit as a share of revenue) fell to 34.6% from 36.6%.

How the business did

  • Revenue and profit: Total revenues were $1,725 million, against $1,606 million a year earlier. Of the increase in core commissions and fees, $156 million came from acquisitions with no revenue in the prior-year quarter. For nine months, total revenues were $5,302 million and income before income taxes was $1,235 million, up 17.6%.
  • Segments: Retail Organic Revenue grew 2.6%. Specialty Distribution Organic Revenue decreased 0.8%, which management tied partly to declining rates on catastrophe property. Specialty Distribution's EBITDAC Margin - Adjusted slipped to 43.3% from 43.9%, which management attributed to the organic decline and investments in Europe.
  • Unusual items: Contingents (commissions based on insurers' underwriting results) were $80 million, up 9.6%. A non-cash credit of $14 million came from the mark-to-market of escrow liability, which reflects the value of shares held back in the Accession deal. The change in estimated acquisition earn-out payables was a $27 million charge. Investment and other income fell to $25 million from $56 million, because the prior-year quarter included interest earned on Accession financing proceeds held before closing.
  • Cash and capital return: Operating cash flow for nine months was $1,140 million, against $1,006 million. In the quarter the company repurchased 3,630,098 shares for $250 million. Total debt at September 30, 2026 was $7,759 million.

What management is watching

  • Measures: Management says it focuses on Organic Revenue growth, growth in Contingents and EBITDAC Margin - Adjusted when judging segments. The filing also notes that Organic Revenue growth and EBITDAC Margin - Adjusted feed executive incentive pay.
  • Spending: The filing points to investments in Europe, higher information technology costs and Acquisition/Integration Costs of $36 million in the quarter. It also reports synergies from the Accession acquisition.
  • Capital: About $650 million remained authorized for share repurchases at September 30, 2026. On October 21, 2026 the board approved a quarterly dividend of $0.18 per share, against $0.165 paid in recent quarters. Estimated acquisition earn-out payables totaled $326 million.
  • Outlook: The MD&A gives no numerical forecast for the rest of the year. It does say management believes cash, operating cash flow and the revolving credit facility are sufficient for liquidity needs over the next twelve months and beyond.

Follow BRO in Kortex

The Kortex app shows BRO's price, options chain and IV rank, and answers your questions from live market data and SEC filings.

Free to download.

Learn the strategies

More stock briefs

For education only, not financial advice. Options involve risk and are not suitable for every investor.